Chikazawa, Kenro https://orcid.org/0000-0002-8839-4483
Imai, Ken https://orcid.org/0000-0002-7593-7960
Kuwata, Tomoyuki https://orcid.org/0000-0002-9334-6670
Konno, Ryo https://orcid.org/0000-0002-9403-1339
Article History
Received: 13 January 2024
Accepted: 9 June 2024
First Online: 17 June 2024
Declarations
:
: K. Chikazawa received lecture honoraria from ETHICON (Tokyo, Japan), TERUMO (Tokyo, Japan), and Chugai Pharmaceutical Co. (Tokyo, Japan). R. Konno received research funding from Yakult Pharmaceutical Industry Co. Ltd. (Tokyo, Japan) and Chugai Pharmaceutical Co. (Tokyo, Japan), as well as lecture honoraria from Japan Vaccine Co. (Tokyo, Japan), MSD Japan (Tokyo, Japan), and Chugai Pharmaceutical Co. (Tokyo, Japan). The remaining authors declare that they have no conflicts of interest.